From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)

Journal of Medicinal Chemistry
Luigi AurelioBernard L Flynn

Abstract

The sphingosine kinase (SK) inhibitor, SKI-II, has been employed extensively in biological investigations of the role of SK1 and SK2 in disease and has demonstrated impressive anticancer activity in vitro and in vivo. However, interpretations of results using this pharmacological agent are complicated by several factors: poor SK1/2 selectivity, additional activity as an inducer of SK1-degradation, and off-target effects, including its recently identified capacity to inhibit dihydroceramide desaturase-1 (Des1). In this study, we have delineated the structure-activity relationship (SAR) for these different targets and correlated them to that required for anticancer activity and determined that Des1 inhibition is primarily responsible for the antiproliferative effects of SKI-II and its analogues. In the course of these efforts, a series of novel SK1, SK2, and Des1 inhibitors have been generated, including compounds with significantly greater anticancer activity.

References

Dec 15, 2000·Current Biology : CB·P XiaM A Vadas
Oct 24, 2002·The Journal of Biological Chemistry·Stuart M PitsonBinks W Wattenberg
Apr 25, 2006·The Journal of Pharmacology and Experimental Therapeutics·Kevin J FrenchCharles D Smith
Dec 13, 2006·Anti-cancer Drugs·Olivier Cuvillier
Feb 6, 2007·Trends in Immunology·Hugh RosenPedro J Gonzalez-Cabrera
Aug 3, 2007·Pharmacology & Therapeutics·Carole A OskeritzianSarah Spiegel
Feb 1, 2008·ChemMedChem·Jose M Munoz-OlayaGemma Fabriàs
Mar 7, 2008·Biochemical Pharmacology·Andrea Huwiler, Josef Pfeilschifter
Sep 13, 2008·Nature Reviews. Immunology·Juan RiveraAna Olivera
Jan 12, 2010·The Journal of Pharmacology and Experimental Therapeutics·Kevin J FrenchCharles D Smith
Feb 25, 2010·The Journal of Pharmacology and Experimental Therapeutics·Vladimir BeljanskiCharles D Smith
Apr 8, 2010·Current Cancer Drug Targets·Melissa R Pitman, Stuart M Pitson
Jul 6, 2010·Bioorganic & Medicinal Chemistry Letters·Yibin XiangMichael Booker
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Luc FuricNahum Sonenberg
Sep 24, 2010·Endocrinology·James W AntoonBarbara S Beckman
Feb 16, 2011·Journal of Molecular Endocrinology·James W AntoonBarbara S Beckman
May 6, 2011·The Journal of Biological Chemistry·Mehrdad RahmaniyanJacqueline M Kraveka
Jun 10, 2011·Current Medicinal Chemistry·P J Edwards, C Sturino
Oct 18, 2011·Trends in Cell Biology·Michael MaceykaSarah Spiegel
Dec 28, 2011·Progress in Lipid Research·Gemma FabriasRiccardo Ghidoni
Feb 7, 2012·Bioinformatics·Darren J CreekMichael P Barrett
Apr 25, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Zu-An ZhuYing Liu
Apr 25, 2012·Methods in Molecular Biology·Melissa R PitmanStuart M Pitson
Jul 4, 2012·The Biochemical Journal·Yugesh KharelWebster L Santos

❮ Previous
Next ❯

Citations

Jun 15, 2016·Cellular Signalling·Melissa R PitmanStuart M Pitson
Dec 16, 2016·Expert Opinion on Therapeutic Patents·Kamal M Dawood, Thoraya A Farghaly
Sep 3, 2016·Oncotarget·Heidi A NeubauerStuart M Pitson
Jun 26, 2020·Organic & Biomolecular Chemistry·Xu WangYing-Ming Pan
Oct 22, 2019·Frontiers in Cell and Developmental Biology·Anika GrafenJürgen Schneider-Schaulies
Feb 28, 2018·International Journal of Molecular Medicine·Mengda CaoJi-Fu Wei
Apr 6, 2019·Current Pharmaceutical Design·Elisa MagliBeatrice Severino
Oct 3, 2020·International Journal of Molecular Sciences·Eileen M McGowanYiguang Lin
Dec 7, 2019·Cancer Cell International·Peng WangXun Qi
Jan 21, 2021·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Seyedeh Roya Alizadeh, Seyedeh Mahdieh Hashemi
Jan 18, 2021·European Journal of Medicinal Chemistry·Tiandi DingBo Liu
Jan 5, 2021·Journal of Medicinal Chemistry·Jan SkácelTakashi Tsukamoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Methods in Enzymology
H SchulzeG van Echten-Deckert
The Journal of Pharmacology and Experimental Therapeutics
Kevin J FrenchCharles D Smith
Journal of Medicinal Chemistry
Deborah S MortensenSabita Sankar
© 2022 Meta ULC. All rights reserved